[6-K] Immuron Limited American Current Report (Foreign Issuer)

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Analyzing...

07/17/2025 - 07:59 AM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Immuron Ltd

NASDAQ:IMRN

IMRN Rankings

#9538 Ranked by Market Cap

N/A Ranked by Dividends

IMRN Latest News

Jul 17, 2025

Immuron - FY25 global sales exceed projection, up 49% on prior year

May 30, 2025

Immuron Letter to Shareholders: Projects Update

Apr 10, 2025

Immuron Travelan® highest sales in history

Mar 5, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Jan 17, 2025

Immuron Travelan® continued strong sales growth

IMRN Latest SEC Filings

Jul 18, 2025

[6-K] Immuron Limited American Current Report (Foreign Issuer)

Jul 17, 2025

[6-K] Immuron Limited American Current Report (Foreign Issuer)

IMRN Stock Data

Market Cap 10.11M

Float 5.85M

Institutions Ownership 0.1%

Short Percent 0.31%

Industry Biotechnology

Sector Healthcare

Website Link

Country Australia

City Carlton